FY 2026 Drug Court Training and Technical Assistance Competitive Cooperative Agreement Solicitation

Office of National Drug Control Policy · United States government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

$6.0M
Est. Value
August 27, 2026
Response Due
Active
Status

Opportunity Overview

<p><span style="color: rgb(34, 34, 34);">ONDCP’s Drug Court Training and Technical Assistance Cooperative Agreement supports training and technical assistance (TTA) to ensure access to evidence-based addiction treatment through drug courts, including when substance use disorder co-occurs with other mental healthconditions. ONDCP seeks to reduce drug use and its consequences through evidence-based treatment that leads to long-term recovery, and this cooperative agreement will support the President’s priorities by applying this to the criminal justice system.&nbsp;The purpose of this cooperative agreement is to: (1) educate, train, and produce materials to improve the implementation of evidence-based treatment to individuals with addiction, including when substance use disorder co-occurs with other mental health conditions; (2)decrease criminal justice costs and recidivism rates; and (3) improve access to evidence-based addiction treatment that includes medications for opioid use disorder through drug courts. The cooperative agreement recipient shall:• Use expert practitioners in the science of addiction and evidence-based addiction treatment, as well as integration of treatment into the criminal justice system.• Use licensed behavioral health practitioners.• Provide in-person training, online training, and jurisdiction-specific technical assistanceto a wide range of geographically distributed areas—including rural locations—at thestate, local, and tribal levels.• Ensure close alignment of all TTA materials with the Trump Administration’s policy priorities, including the 2026 National Drug Control Strategy; an evidence-based approach to treating addiction--to include FDA-approved medications for opioid use disorder--contingency management, and other evidence-based behavioral health modalities for other substance use disorders; naloxone distribution and naloxone training.• Designate and fund a research or academic organization to conduct an independent assessment of...

This is one of 897 active United States Other opportunities most of your competitors will never see.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyOffice of National Drug Control Policy
CountryUnited States
CategoryOther
Estimated value$6.0M
NAICS95.005
PublishedJuly 15, 2026
Procurement stageRequest for Proposal (RFP)
Response dueAugust 27, 2026
StatusOpen — accepting responses
Official sourceView original notice
Last verifiedAugust 12, 2026

Source: U.S. Government (Simpler.Grants.gov) — public domain. Not affiliated with or endorsed by the United States Government.

Related Opportunities in United States

Applied Drug Policy Research Experiences
Applied Drug Policy Research Experiences
PPVG GEN V Award
State Border Security Reinforcement Fund
FY 2026 Continuum of Care Competition and Youth Homelessness Demonstration Program Grants NOFO
Advancing Global Health
Advancing Global Health
Advancing Global Health

See every United States Other opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free United States Other intelligence report in your inbox

A personalized report on United States Other opportunities, emailed in 5-10 minutes. One per month, no account needed.